BAMOMAB

BAMOMAB GmbH, established in 2006, specializes in providing high-quality reagents for immunological research. These reagents include novel monoclonal antibodies and ELISA kits developed in collaboration with the Department of Immunology at the University of Tübingen.

Product Offerings:

• Monoclonal Antibodies: BAMOMAB offers antibodies targeting MICA and MICB proteins, such as:
• BAMO1: Recognizes both MICA and MICB proteins.
• AMO1: Specific to MICA.
• BMO2: Specific to MICB.
• ELISA Kits: The company provides sandwich ELISA kits designed for the detection of soluble MICA (sMICA), facilitating research in immunology and related fields